Deciphering the role of CX3CR1 in Modulating Mechanisms of Amyloid driven Neurodegeneration in Alzheimer's Disease (Diversity Supplement)

破译 CX3CR1 在阿尔茨海默氏病淀粉样蛋白驱动的神经变性调节机制中的作用（多样性补充）

• 批准号: 10524900
• 负责人: Bruce T Lamb
• 金额: $ 13.61万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-15 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10524900
• 关键词: AD transgenic mice; Affect; Alzheimer' s Disease; Amyloid; Amyloid beta-Protein; Autopsy; Award; Binding; Brain; CRISPR/Cas technology; CX3CL1 gene; CX3CR1 gene; Cell Line; Cell Nucleus; Chronic; Coculture Techniques; Communication; Data; Deposition; Disease; Down-Regulation; Event; Foundations; Frameshift Mutation; Functional disorder; Generations; Genes; Genetic Screening; Homeostasis; Human; Immunologics; Impaired cognition; Impairment; Inflammatory; Injections; Knock-out; Ligands; Light; Microglia; Mus; Mutation; Nerve Degeneration; Neurodegenerative Disorders; Neurofibrillary Tangles; Neuroglia; Neurons; Parents; Pathogenesis; Pathologic; Pathology; Patients; Phagocytes; Phenotype; Population; Proteins; Reporting; Risk Factors; Role; Senile Plaques; Shapes; Signal Transduction; Synapses; Technology; Testing; Therapeutic; Tissues; Variant; abeta deposition; abeta oligomer; base; design; disease phenotype; extracellular; genetic analysis; genetic variant; homologous recombination; hyperphosphorylated tau; immune activation; in vitro Assay; induced pluripotent stem cell; insertion/deletion mutation; intercellular communication; loss of function mutation; mouse model; neurofibrillary tangle formation; neuroinflammation; neuron loss; neurotoxic; presenilin-1; prodromal Alzheimer' s disease; receptor; receptor function; response; tau Proteins; transcriptome sequencing

The amyloid-cascade hypothesis states that deposition of extracellular Aβ plaques is the primary event in AD that facilitates accumulation of hyperphosphorylated tau (pTau), formation of neurofibrillary tangles (NFTs) and drives subsequent neurodegeneration. Microglial activation is the earliest response to pathological changes in the brain and is known to shape neuronal activity and immune activation of neighboring glial cells. Thus, how Aβ-driven microglial activation shapes neurodegenerative signaling in AD is a critical unknown in current therapeutic approaches. Communication between microglia and neurons via microglial CX3CR1 and its neuronal ligand is a central signaling checkpoint that shapes the immunological niche in AD. RNA sequencing studies have postulated that downregulation of microglial CX3CR1 is a neuroprotective response. By contrast, our data suggests that the loss of CX3CR1 increases accumulation of toxic, soluble Aβ species which correlate with increased synaptic dysfunction, pTau pathology and neurodegeneration. Indeed, recent reports have associated CX3CR1-V249I, a mutation which impairs CX3CR1 function, with increased NFT pathology and worsened neurodegeneration in AD patients. This proposal aims to test the unique hypothesis that downregulation/loss of CX3CR1 signaling alters microglial activation and results in impaired clearance and/or increased accumulation of neurotoxic soluble Aβ oligomers. Enrichment of toxic Aβ in the micro-environment triggers a cascade of neurodegenerative signaling including the generation and spread of neurotoxic species of pTau. Using the single-nuclei sequencing approach we propose an unbiased genetic screen to assess how CX3CR1 alters neurodegenerative, phagocytic and neuroinflammatory signaling in early vs. late stages of AD. Results of this broad genetic analysis will be validated by a deep pathological phenotyping of the disease using 5xFAD and APPPS1 transgenic AD mice deficient in CX3CR1 signaling (Aim 1). To investigate how a toxic Aβ milieu in the absence of CX3CR1 can drive neurodegeneration, we will assess the propagation and spread of pathological tau species following stereotaxic injection of toxic tau from post-mortem AD tissue into the brains of 5xFAD mice with and without CX3CR1 (Aim 2). Lastly, to understand how the human V249I variant affects neurodegenerative responses, we will use CRISPER-Cas9 technology to generate human iPSC derived microglia with CX3CR1 harboring the V429I (loss-of-function) mutation and isogenic iPS-derived AD neurons expressing M146L and L286V mutations in the PSEN1 gene. Co-culture of human-derived microglia with isogenic AD neurons will be used to assess a) how the V249I mutation shapes Aβ driven neurotoxic microglial activation and b) how Aβ-activated V249I+ microglia alter neuronal activity and affect neurodegenerative signalling/pathology (Aim 3). Combining the use of transgenic AD mouse models and human iPSC based in-vitro assays, this proposal will shed light on the overarching effects of CX3CR1 on Aβ-driven neurodegeneration in the cascade of AD pathogenesis.

淀粉样蛋白级联假说认为细胞外β斑块的沉积是AD的主要事件